As of today (2024-04-23), Sinopharm Group Co's share price is $2.61.
Sinopharm Group Co's Owner Earnings per Share (TTM) ended in Dec. 2023 was $0.36. It's Price-to-Owner-Earnings for today is 7.25.
The historical rank and industry rank for Sinopharm Group Co's Price-to-Owner-Earnings or its related term are showing as below:
SHTDF'
s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.61 Med: 8.12 Max: 9.49
Current: 7.21
During the past 13 years, the highest Price-to-Owner-Earnings of Sinopharm Group Co was 9.49. The lowest was 6.61. And the median was 8.12.
As of today (2024-04-23), Sinopharm Group Co's share price is $2.61.
Sinopharm Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $0.39. Therefore, Sinopharm Group Co's PE Ratio for today is 6.62.
As of today (2024-04-23), Sinopharm Group Co's share price is $2.61.
Sinopharm Group Co's EPS without NRI for the trailing twelve months (TTM) ended in was $0.48. Therefore, Sinopharm Group Co's PE Ratio without NRI for today is 5.41.
During the past 13 years, Sinopharm Group Co's highest PE Ratio without NRI was 7.23. The lowest was 3.22. And the median was 5.42.
Sinopharm Group Co Price-to-Owner-Earnings Historical Data
The historical data trend for Sinopharm Group Co's Price-to-Owner-Earnings can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Sinopharm Group Co Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Owner-Earnings |
|
Get a 7-Day Free Trial
|
|
|
9.00 |
123.50 |
- |
6.84 |
- |
|
Sinopharm Group Co Quarterly Data
|
|
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Sep22 |
Dec22 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Owner-Earnings |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
6.84 |
- |
- |
- |
Competitive Comparison
For the Medical Distribution subindustry, Sinopharm Group Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co Price-to-Owner-Earnings Distribution
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Price-to-Owner-Earnings distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's Price-to-Owner-Earnings falls into.
Sinopharm Group Co Price-to-Owner-Earnings Calculation
In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:
"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."
Sinopharm Group Co's Price-to-Owner-Earnings for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co (Sinopharm Group Co) Business Description
Traded in Other Exchanges
Address
No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Sinopharm Group was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Its main business is drug distribution in mainland China, which contributes about 75% of total revenue. It is the largest drug distributor, with approximately 20% market share. Other notable segments are medical device distribution, which contributes about 20% of revenue, and retail pharmacies, which contributes about 5%. These are fast-growing industries, where government policy is designed to encourage consolidation and promote large players with scale and efficiency advantages.
Sinopharm Group Co (Sinopharm Group Co) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHTDF has been successfully added to your